Liver Cancer Newswire (Page 2)

Comprehensive Real-Time News Feed for Liver Cancer. (Page 2)

Results 21 - 40 of 4,241 in Liver Cancer

  1. Compugen Discloses Successful Validation Results for Novel...Read the original story

    Monday Oct 27 | Customer Interaction Solutions

    Ltd. today disclosed successful experimental data for CGEN-15027, a Compugen-discovered immune checkpoint target candidate. The experimental results include its expression in the cancer microenvironment, both on cancer cells derived from lung, breast, and liver cancer patients, and on tumor infiltrating immune cells.

    Comment?

  2. Compugen Discloses Successful Validation Results for Novel...Read the original story

    Monday Oct 27 | Sys-Con Media

    Compugen Ltd. today disclosed successful experimental data for CGEN-15027, a Compugen-discovered immune checkpoint target candidate. The experimental results include its expression in the cancer microenvironment, both on cancer cells derived from lung, breast, and liver cancer patients, and on tumor infiltrating immune cells.

    Comment?

  3. uniQure Release: Presents 1 Year Follow-Up Clinical Data From Acute...Read the original story

    Monday Oct 27 | BioSpace

    ... in the PBGD gene. AIP can be life threatening and the long-term effects include irreversible nerve damage, liver cancer and kidney failure. AMT-021 consists of the PBGD gene encapsulated in the AAV5 viral vector and is designed to enable ...

    Comment?

  4. Compugen Discloses Successful Validation Results for Novel...Read the original story

    Monday Oct 27 | Business Wire

    Compugen Ltd. today disclosed successful experimental data for CGEN-15027, a Compugen-discovered immune checkpoint target candidate. The experimental results include its expression in the cancer microenvironment, both on cancer cells derived from lung, breast, and liver cancer patients, and on tumor infiltrating immune cells.

    Comment?

  5. VIDEO: Friends remember Aaron at charity football matchRead the original story w/Photo

    Monday Oct 27 | Bucksfreepress.co.uk

    ... also launched into the sky before the match kicked off. Aaron, a promising goalkeeper, died from a rare form of liver cancer four years ago, two days before a fundraising match to help kickstart his dream of setting up a sports academy for ...

    Comment?

  6. Useful markers to predict response to chemotherapy in patients with liver cancerRead the original story w/Photo

    Monday Oct 27 | Medical News Today

    A study led by the researcher at the Institute of Biomedical Research , Isabel Fabregat, could serve to select patients with hepatocellular carcinoma unresponsive to most frequently used drug in liver cancer: sorafenib. The study, published in the International Journal of Cancer describes how tumor cells that have a less differentiated phenotype and expresses CD44, do not respond to Sorafenib action.

    Comment?

  7. Molecular biology of liver cancer stem cells.Read the original story

    Sunday Oct 26 | CiteULike

    Hepatocellular carcinoma is one of the most common and lethal cancers worldwide. The concept of cancer stem cells is based primarily on the clinical and experimental observations that indicate the existence of a subpopulation of cells with the capacity to self-renew and differentiate as well as show increased resistance to radiation and chemotherapy.

    Comment?

  8. Prevention of hepatitis C virus infection and liver cancer.Read the original story

    Sunday Oct 26 | CiteULike

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer , Vol.

    Comment?

  9. Statin use and risk of liver cancer: an update meta-analysis.Read the original story

    Sunday Oct 26 | CiteULike

    ... The primary objective of this meta-analysis was to determine the association between statin use and risk of liver cancer. Meta-analysis. International. A comprehensive literature search of PubMed, BIOSIS Previews, Web of Science, EMBASE, EBSCO and ...

    Comment?

  10. Drug therapy for advanced-stage liver cancer.Read the original story

    Sunday Oct 26 | CiteULike

    Liver cancer was traditionally treated by surgery or interventional ablative treatments, or, if these options were not feasible, by best supportive care. Since 2008, systemic therapy with the multikinase inhibitor sorafenib has become available worldwide and has become the standard of care for unresectable/non-ablatable or advanced-stage hepatocellular carcinoma .

    Comment?

  11. Systemic treatment.Read the original story

    Sunday Oct 26 | CiteULike

    In the last years the management of patients with liver cancer has been improved. The BCLC staging/treatment strategy identifies the optimal candidates for each treatment option and sorafenib is the only effective systemic treatment.

    Comment?

  12. Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance.Read the original story

    Sunday Oct 26 | CiteULike

    ... focusing on biomarkers; the contribution of cell death to drug-induced, viral, and fatty liver disease and liver cancer; and evidence for cell death pathways as therapeutic targets. Copyright A 2014 AGA Institute. Published by Elsevier Inc. ...

    Comment?

  13. Role of antiviral treatment for HCC prevention.Read the original story

    Sunday Oct 26 | CiteULike

    ... for risk factors of HCC, provided a clue to find an association between NUC therapy and a reduced risk of liver cancer in non cirrhotic patients, only. In the hepatitis C scenario, a meta analysis of 30 observational studies of patients treated with ...

    Comment?

  14. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.Read the original story

    Sunday Oct 26 | CiteULike

    ... facets of tea polyphenols are responsible for its anticancer properties. Several lethal cancers, such as liver cancer, develop within a background of oxidative stress and inflammation. Liver cancer, also known as hepatocellular carcinoma (HCC), has ...

    Comment?

  15. How Gilead Sciences Inc. Isn't Gouging Hepatitis C Patients, in 1 Simple InfographicRead the original story w/Photo

    Sunday Oct 26 | The Motley Fool

    ... to factor in the savings to the healthcare system. Many hepatitis C patients left untreated will eventually get liver cancer or cirrhosis that can lead to liver failure. A liver transplant cost a lot more than $75,000. Finally, there's the ...

    Comment?

  16. Jake Bruce was grateful for 'miraculous' liver transplantRead the original story w/Photo

    Sunday Oct 26 | ContactMusic.com

    ... to music after he had to quit in 2003 because of his devastating health issues after being diagnosed with liver cancer, as a result of former drug abuse. This year he released his first solo album in almost 10 years, 'Silver Rails', after being ...

    Comment?

  17. High levels of toxic molds identified in herbal medicinesRead the original story w/Photo

    Sunday Oct 26 | Medical News Today

    ... mycotoxins. At high levels, these mycotoxins can trigger adverse effects in humans. They have been linked to liver cancer , kidney damage, reproductive disorders and immune system suppression. Despite the risks herbal medicines may pose, however, ...

    Comment?

  18. Cream bassist Jack Bruce dead at 71Read the original story w/Photo

    Saturday Oct 25 | MassLive.com

    ... at the suffered from liver disease. He had undergone a liver transplant a decade ago after being diagnosed with liver cancer. They reunited for a series of shows at the Royal Albert Hall in London and Madison Square Garden in New York in 2005.

    Comment?

  19. Friends: Menino weak, but still cracking jokesRead the original story w/Photo

    Saturday Oct 25 | TheBostonChannel.com

    Former Boston Mayor Thomas Menino said Thursday he is suspending treatment for an advanced form of cancer as well as a recently-launched book tour to spend more time with his family and friends. SURVIVOR DR.

    Comment?

  20. Meals For Life at The Express Coffee ShopRead the original story

    Friday Oct 24 | Feather River Bulletin

    Oct. 25 to aid the sister-in-law of the owner, Lucio Macias in her fight with liver cancer. Josefina Rodriquez contracted Hepatitis C some time ago.

    Comment?